Skip to main content
Top
Published in: Current Psychiatry Reports 6/2013

01-06-2013 | Geriatric Disorders (H Lavretsky, Section Editor)

Geriatric Psychiatry Review: Differential Diagnosis and Treatment of the 3 D’s - Delirium, Dementia, and Depression

Authors: Lisa J. Downing, Thomas V. Caprio, Jeffrey M. Lyness

Published in: Current Psychiatry Reports | Issue 6/2013

Login to get access

Abstract

The three D’s of Geriatric Psychiatry—delirium, dementia, and depression—represent some of the most common and challenging diagnoses for older adults. Delirium is often difficult to diagnose and treatment is sometimes controversial with the use of antipsychotic medications, but it is common in a variety of patient care settings and remains an independent risk factor for morbidity and mortality in older adults. Dementia may affect a significant number of older adults and is associated with delirium, depression, frailty, and failure to thrive. Treatment of dementia is challenging and while medication interventions are common, environmental and problem solving therapies may have some of the greatest benefits. Finally, depression increases with age and is more likely to present with somatic complaints or insomnia and is more likely to be reported to a primary care physician than any other healthcare provider by older adults. Depression carries an increased risk for suicide in older adults and proven therapies should be initiated immediately. These three syndromes have great overlap, can exist simultaneously in the same patient, and often confer increased risk for each other. The primary care provider will undoubtedly benefit from a solid foundation in the identification, classification, and treatment of these common problems of older adulthood.
Literature
1.
go back to reference • Cole MG, McCusker J, Voyer P, et al. Subsyndromal delirium in older long-term care residents. Incidence, risk factors, and outcomes. J Am Geriatr Soc. 2011;59:1829–36. This prospective cohort study of older adults describes risk factors for developing delirium in long-term care residents. PubMedCrossRef • Cole MG, McCusker J, Voyer P, et al. Subsyndromal delirium in older long-term care residents. Incidence, risk factors, and outcomes. J Am Geriatr Soc. 2011;59:1829–36. This prospective cohort study of older adults describes risk factors for developing delirium in long-term care residents. PubMedCrossRef
2.
go back to reference Lyness JM. Delirium: masquerades and misdiagnosis in elderly inpatients. J Am Geriatr Soc. 1990;38(11):1235–8.PubMed Lyness JM. Delirium: masquerades and misdiagnosis in elderly inpatients. J Am Geriatr Soc. 1990;38(11):1235–8.PubMed
3.
go back to reference Voyer P, McMusker J, Cole MG, et al. Prodrome of delirium among long term care residents: what clinical changes can be observed in the two weeks preceding a full-blown episode of delirium? Int Psychogeriatr. 2012;24(11):1855–64.PubMedCrossRef Voyer P, McMusker J, Cole MG, et al. Prodrome of delirium among long term care residents: what clinical changes can be observed in the two weeks preceding a full-blown episode of delirium? Int Psychogeriatr. 2012;24(11):1855–64.PubMedCrossRef
4.
go back to reference • Witlox J, Eurelings LS, de Jonghe JF, et al. Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. JAMA. 2010;304(4):443–51. This meta-analysis showed long-term poor outcomes after delirium in older patients. PubMedCrossRef • Witlox J, Eurelings LS, de Jonghe JF, et al. Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. JAMA. 2010;304(4):443–51. This meta-analysis showed long-term poor outcomes after delirium in older patients. PubMedCrossRef
5.
go back to reference •• Flaherty JH, Gonzales JP, Dong B. Antipsychotics in the treatment of delirium in older hospitalized adults: a systematic review. J Am Geriatr Soc. 2011;59:S269–276. This systematic literature review did not support the use of antipsychotics in the treatment of delirium in older hospitalized patients. PubMedCrossRef •• Flaherty JH, Gonzales JP, Dong B. Antipsychotics in the treatment of delirium in older hospitalized adults: a systematic review. J Am Geriatr Soc. 2011;59:S269–276. This systematic literature review did not support the use of antipsychotics in the treatment of delirium in older hospitalized patients. PubMedCrossRef
6.
go back to reference •• Morandi A, McCurley J, Vasilevskis EE, et al. Tools to detect delirium superimposed on dementia: a systematic review. J Am Geriatr Soc. 2012;60(11):2005–13. This systematic literature review validated the CAM as a sensitive and specific tool for detecting delirium in the setting of dementia. PubMed •• Morandi A, McCurley J, Vasilevskis EE, et al. Tools to detect delirium superimposed on dementia: a systematic review. J Am Geriatr Soc. 2012;60(11):2005–13. This systematic literature review validated the CAM as a sensitive and specific tool for detecting delirium in the setting of dementia. PubMed
7.
go back to reference Inouye SK, Van Dyck CH, Alessi CA, et al. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990;113(12):941–8.PubMedCrossRef Inouye SK, Van Dyck CH, Alessi CA, et al. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990;113(12):941–8.PubMedCrossRef
8.
go back to reference Kopke S, Muhlhauser, Gerlach A, et al. Effect of a guideline-based multicomponent intervention on use of physical restraints in nursing homes. JAMA. 2012;307(20):2177–84.PubMedCrossRef Kopke S, Muhlhauser, Gerlach A, et al. Effect of a guideline-based multicomponent intervention on use of physical restraints in nursing homes. JAMA. 2012;307(20):2177–84.PubMedCrossRef
9.
go back to reference Morley JE. Behavioral management in the person with dementia. J Nutr Health Aging. 2013;17(1):35–8.PubMedCrossRef Morley JE. Behavioral management in the person with dementia. J Nutr Health Aging. 2013;17(1):35–8.PubMedCrossRef
10.
go back to reference Breitbart W, Alici Y. Evidence-based treatment of delirium in patients with cancer. J Clin Oncol. 2012;30(11):1206–14.PubMedCrossRef Breitbart W, Alici Y. Evidence-based treatment of delirium in patients with cancer. J Clin Oncol. 2012;30(11):1206–14.PubMedCrossRef
12.
go back to reference •• Saczynski JS, Marcantonio ER, Quach L, et al. Cognitive trajectories after postoperative delirium. NEJM. 2012;367(1):30–9. This observational study found significant delirium risk with prolonged impact on cognitive functioning in older post-operative patients who underwent cardiac surgery. PubMedCrossRef •• Saczynski JS, Marcantonio ER, Quach L, et al. Cognitive trajectories after postoperative delirium. NEJM. 2012;367(1):30–9. This observational study found significant delirium risk with prolonged impact on cognitive functioning in older post-operative patients who underwent cardiac surgery. PubMedCrossRef
13.
go back to reference Davis DH, Terrera GM, Keage H, et al. Delirium is a strong risk factor for dementia in the oldest-old: a population-based cohort study. Brain. 2012;135:2809–16.PubMedCrossRef Davis DH, Terrera GM, Keage H, et al. Delirium is a strong risk factor for dementia in the oldest-old: a population-based cohort study. Brain. 2012;135:2809–16.PubMedCrossRef
14.
go back to reference Yiannopoulou KG, Papageorgiou SG. Current and future treatments for Alzheimer’s disease. Ther Adv Neurol Disord. 2012;6(1):19–33.CrossRef Yiannopoulou KG, Papageorgiou SG. Current and future treatments for Alzheimer’s disease. Ther Adv Neurol Disord. 2012;6(1):19–33.CrossRef
15.
go back to reference Kalapatapu RK, Neugroschl JA. Update on neuropsychiatric symptoms of dementia: evaluation and management. Geriatrics. 2009;64(4):20–6.PubMed Kalapatapu RK, Neugroschl JA. Update on neuropsychiatric symptoms of dementia: evaluation and management. Geriatrics. 2009;64(4):20–6.PubMed
17.
go back to reference Newman JC, Feldman RF. Perspective-copyright and open access at the bedside. NEJM. 2011;365:2447–9.PubMedCrossRef Newman JC, Feldman RF. Perspective-copyright and open access at the bedside. NEJM. 2011;365:2447–9.PubMedCrossRef
18.
go back to reference Dong Y, Lee WY, Basri NA, et al. The Montreal cognitive assessment is superior to the mini-mental state examination in detecting patients at higher risk of dementia. Int Psychogeriatr. 2012;24(11):1749–55.PubMedCrossRef Dong Y, Lee WY, Basri NA, et al. The Montreal cognitive assessment is superior to the mini-mental state examination in detecting patients at higher risk of dementia. Int Psychogeriatr. 2012;24(11):1749–55.PubMedCrossRef
19.
go back to reference Geda YE, Silber TC, Roberts RO, et al. Computer activities, physical exercise, aging, and mild cognitive impairment: a population-based study. Mayo Clin Proc. 2012;87(5):437–42.PubMedCrossRef Geda YE, Silber TC, Roberts RO, et al. Computer activities, physical exercise, aging, and mild cognitive impairment: a population-based study. Mayo Clin Proc. 2012;87(5):437–42.PubMedCrossRef
20.
go back to reference Meng X, D’Arcy C. Education and dementia in the contrext of the cognitive reserve hypothesis: a systematic review with meta-analyses and qualitative analyses. PLoS One. 2012;7(6):e38268.PubMedCrossRef Meng X, D’Arcy C. Education and dementia in the contrext of the cognitive reserve hypothesis: a systematic review with meta-analyses and qualitative analyses. PLoS One. 2012;7(6):e38268.PubMedCrossRef
21.
go back to reference Vellas B, Coley N, Ousset PJ, et al. Long-term use of standardized Ginkgo biloba extract for the prevention of Alzheimer’s disease (GuidAge): a randomized placebo-controlled trial. Lancet Neurol. 2012;11(10):85109.CrossRef Vellas B, Coley N, Ousset PJ, et al. Long-term use of standardized Ginkgo biloba extract for the prevention of Alzheimer’s disease (GuidAge): a randomized placebo-controlled trial. Lancet Neurol. 2012;11(10):85109.CrossRef
22.
go back to reference St DK, Williamson JD, Fitzpatrick AL, et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA. 2008;300(19):2253–62.CrossRef St DK, Williamson JD, Fitzpatrick AL, et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA. 2008;300(19):2253–62.CrossRef
23.
go back to reference Malouf R, Grimley Evans J. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst Rev. 2008;Oct(4):CD004514. Malouf R, Grimley Evans J. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst Rev. 2008;Oct(4):CD004514.
24.
go back to reference Syndenham E, Dangour AD, Lim WS. Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst Rev. 2012;6, CD005379. Syndenham E, Dangour AD, Lim WS. Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst Rev. 2012;6, CD005379.
25.
go back to reference Aisen PS, Schafer KA, Grundman M, et al. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA. 2003;289(21):2819–26.PubMedCrossRef Aisen PS, Schafer KA, Grundman M, et al. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA. 2003;289(21):2819–26.PubMedCrossRef
26.
go back to reference • Alexopoulos GS, Raue PJ, Kiosses DN, et al. Problem solving therapy and supportive therapy in older adults with major depression and executive dysfunction: effect on disability. Arch Gen Psychiatry. 2011;68(1):33–41. This prospective cohort study of older adults describes risk factors for developing delirium in long-term care residents. PubMedCrossRef • Alexopoulos GS, Raue PJ, Kiosses DN, et al. Problem solving therapy and supportive therapy in older adults with major depression and executive dysfunction: effect on disability. Arch Gen Psychiatry. 2011;68(1):33–41. This prospective cohort study of older adults describes risk factors for developing delirium in long-term care residents. PubMedCrossRef
27.
go back to reference Mukamel DB, Caprio TV, Ahn R, et al. End-of-life quality-of-care measures for nursing homes: place of death and hospice. J Palliat Med. 2012;15(4):438–46.PubMedCrossRef Mukamel DB, Caprio TV, Ahn R, et al. End-of-life quality-of-care measures for nursing homes: place of death and hospice. J Palliat Med. 2012;15(4):438–46.PubMedCrossRef
28.
go back to reference Grisso T, Appelbaum PS, Hill-Fotouhi C. The MacCAT-T: a clinical tool to assess patients’ capacities to make treatment decisions. Psychiatr Serv. 1997;48(11):1415–9.PubMed Grisso T, Appelbaum PS, Hill-Fotouhi C. The MacCAT-T: a clinical tool to assess patients’ capacities to make treatment decisions. Psychiatr Serv. 1997;48(11):1415–9.PubMed
29.
go back to reference Kim SY, Caine ED, Currier GW, et al. Assessing the competence of persons with Alzheimer’s disease in providing informed consent for participation in research. Am J Psychiatry. 2001;158(5):712–7.PubMedCrossRef Kim SY, Caine ED, Currier GW, et al. Assessing the competence of persons with Alzheimer’s disease in providing informed consent for participation in research. Am J Psychiatry. 2001;158(5):712–7.PubMedCrossRef
30.
go back to reference Carroll DW. Assessment of capacity for medical decision making. J Gerontol Nurs. 2010;36(5):47–52.PubMedCrossRef Carroll DW. Assessment of capacity for medical decision making. J Gerontol Nurs. 2010;36(5):47–52.PubMedCrossRef
31.
go back to reference Qato DM, Alexander GC, Conti RM, et al. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA. 2008;300(24):2867–78.PubMedCrossRef Qato DM, Alexander GC, Conti RM, et al. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA. 2008;300(24):2867–78.PubMedCrossRef
32.
go back to reference Tjia J, Rothman MR, Kiely DK, et al. Daily medication use in nursing home residents with advanced dementia. J Am Geriatr Soc. 2010;58(5):880–8.PubMedCrossRef Tjia J, Rothman MR, Kiely DK, et al. Daily medication use in nursing home residents with advanced dementia. J Am Geriatr Soc. 2010;58(5):880–8.PubMedCrossRef
33.
go back to reference Maher AR, Maglione M, Bagley S, et al. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults. JAMA. 2011;306(12):1359–69.PubMedCrossRef Maher AR, Maglione M, Bagley S, et al. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults. JAMA. 2011;306(12):1359–69.PubMedCrossRef
34.
go back to reference Kalapatapu RK, Schimmin C. Update on neuropsychiatric symptoms of dementia: antipsychotic use. Geriatrics. 2009;64(5):10–8.PubMed Kalapatapu RK, Schimmin C. Update on neuropsychiatric symptoms of dementia: antipsychotic use. Geriatrics. 2009;64(5):10–8.PubMed
35.
go back to reference Devanand DP, Pelton GH, Cunqueiro K, et al. A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer’s disease. Int J Geriatr Psychiatry. 2011;26(9):937–43.PubMedCrossRef Devanand DP, Pelton GH, Cunqueiro K, et al. A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer’s disease. Int J Geriatr Psychiatry. 2011;26(9):937–43.PubMedCrossRef
36.
go back to reference Murse J, Robien K, Harnack LJ, et al. Dietary supplements and mortality rate in older women: the Iowa women’s health study. Arch Intern Med. 2011;171(18):1625–33.CrossRef Murse J, Robien K, Harnack LJ, et al. Dietary supplements and mortality rate in older women: the Iowa women’s health study. Arch Intern Med. 2011;171(18):1625–33.CrossRef
37.
go back to reference Fried LP, Ferrucci L, Darer J, et al. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004;59(3):255–63.PubMedCrossRef Fried LP, Ferrucci L, Darer J, et al. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004;59(3):255–63.PubMedCrossRef
38.
go back to reference Andrew MK, Fisk JD, Rockwood K. Psychological well-being in relation to frailty: a frailty identity crisis? Int Psychogeriatr. 2012;24(8):1347–53.PubMedCrossRef Andrew MK, Fisk JD, Rockwood K. Psychological well-being in relation to frailty: a frailty identity crisis? Int Psychogeriatr. 2012;24(8):1347–53.PubMedCrossRef
39.
go back to reference Rodriguez-manas L, Feart C, Mann G, et al. Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project. J Gerontol A Biol Sci Med Sci. 2013;68(1):62–7.PubMedCrossRef Rodriguez-manas L, Feart C, Mann G, et al. Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project. J Gerontol A Biol Sci Med Sci. 2013;68(1):62–7.PubMedCrossRef
40.
go back to reference NiMhaolain AM, Fan CW, Romero-Ortuno R, et al. Frailty, depression, and anxiety in later life. Int Psychogeriatr. 2012;24(8):1265–74.CrossRef NiMhaolain AM, Fan CW, Romero-Ortuno R, et al. Frailty, depression, and anxiety in later life. Int Psychogeriatr. 2012;24(8):1265–74.CrossRef
41.
go back to reference •• Boyle LL, Porteinsson AP, Cui X, et al. Depression predicts cognitive disorders in older primary care patients. J Clin Psychiatry. 2010;71(1):74–9. This prospective cohort study showed that depression is associated with development of cognitive decline in older patients. PubMedCrossRef •• Boyle LL, Porteinsson AP, Cui X, et al. Depression predicts cognitive disorders in older primary care patients. J Clin Psychiatry. 2010;71(1):74–9. This prospective cohort study showed that depression is associated with development of cognitive decline in older patients. PubMedCrossRef
42.
go back to reference •• Firbank MJ, Teodorczuk A, van der Flier WM, et al. Relationship between progression of brain white matter changes and late-life depression: 3-year results from the LADIS study. BJP. 2012;201:40–5. This longitudinal study showed that progression of white matter changes was significantly associated with incidence of depression in older patients. CrossRef •• Firbank MJ, Teodorczuk A, van der Flier WM, et al. Relationship between progression of brain white matter changes and late-life depression: 3-year results from the LADIS study. BJP. 2012;201:40–5. This longitudinal study showed that progression of white matter changes was significantly associated with incidence of depression in older patients. CrossRef
43.
go back to reference Lyness JM, Yu Q, Tang W, et al. Risks for depression onset in primary care elderly patients: potential targets for preventive interventions. Am J Psychiatry. 2009;166(12):1375–83.PubMedCrossRef Lyness JM, Yu Q, Tang W, et al. Risks for depression onset in primary care elderly patients: potential targets for preventive interventions. Am J Psychiatry. 2009;166(12):1375–83.PubMedCrossRef
44.
go back to reference Harmon JS, Veazie PJ, Lyness JM. Primary care physician office visits for depression by older Americans. J Gen Intern Med. 2006;21:926–30.CrossRef Harmon JS, Veazie PJ, Lyness JM. Primary care physician office visits for depression by older Americans. J Gen Intern Med. 2006;21:926–30.CrossRef
45.
go back to reference Bland P. Tackling anxiety and depression in older people in primary care. Practitioner. 2012;256(1747):17–20.PubMed Bland P. Tackling anxiety and depression in older people in primary care. Practitioner. 2012;256(1747):17–20.PubMed
46.
go back to reference Lyness JM, Chapman BP, McGriff J, et al. One-year outcomes of minor and subsyndromic depression in older primary care patients. Int Psychogeriatr. 2009;21(1):60–8.PubMedCrossRef Lyness JM, Chapman BP, McGriff J, et al. One-year outcomes of minor and subsyndromic depression in older primary care patients. Int Psychogeriatr. 2009;21(1):60–8.PubMedCrossRef
47.
go back to reference • Byers AL, Vittinghoff E, Lui L, et al. Twenty-year depressive trajectories among older women. Arch Gen Psychiatry. 2012;69(10):1073–9. This prospective cohort study followed women with depression from age 65 years old to 85 years old and found many women with persistent or worsening depression symptoms over time. PubMedCrossRef • Byers AL, Vittinghoff E, Lui L, et al. Twenty-year depressive trajectories among older women. Arch Gen Psychiatry. 2012;69(10):1073–9. This prospective cohort study followed women with depression from age 65 years old to 85 years old and found many women with persistent or worsening depression symptoms over time. PubMedCrossRef
48.
go back to reference Ellison JM, Kyomen HH, Harper DG. Depression in later life: an overview with treatment recommendations. Psychiatr Clin N Am. 2012;35:203–29.CrossRef Ellison JM, Kyomen HH, Harper DG. Depression in later life: an overview with treatment recommendations. Psychiatr Clin N Am. 2012;35:203–29.CrossRef
49.
go back to reference Maurer DM. Screening for depression. Am Fam Physician. 2012;85(2):140–4. Maurer DM. Screening for depression. Am Fam Physician. 2012;85(2):140–4.
50.
go back to reference Bloom HG, Ahmed I, Alessi CA, et al. Evidence-based recommendations for the assessment and management of sleep disorders in older persons. J Am Geriatr Soc. 2009;57(5):761–89.PubMedCrossRef Bloom HG, Ahmed I, Alessi CA, et al. Evidence-based recommendations for the assessment and management of sleep disorders in older persons. J Am Geriatr Soc. 2009;57(5):761–89.PubMedCrossRef
51.
go back to reference Perlis ML, Smith LJ, Lyness JM, et al. Insomnia as a risk factor for the onset of depression in the elderly. Behav Sleep Med. 2006;4(2):104–13.PubMedCrossRef Perlis ML, Smith LJ, Lyness JM, et al. Insomnia as a risk factor for the onset of depression in the elderly. Behav Sleep Med. 2006;4(2):104–13.PubMedCrossRef
52.
go back to reference Tang QK, Lu JY, Liang H, et al. Is insomnia associated with suicidality in stroke? Arch Phys Med Rehabil. 2011;92(12):2025–7.PubMedCrossRef Tang QK, Lu JY, Liang H, et al. Is insomnia associated with suicidality in stroke? Arch Phys Med Rehabil. 2011;92(12):2025–7.PubMedCrossRef
53.
go back to reference •• Martin JL, Fiorentino L, Jouldjian S, et al. Poor self-reported sleep quality predicts mortality within one year of inpatient post-acute rehabilitation among older adults. Sleep. 2011;34(12):1715–21. This prospective cohort study found increased mortality associated with poor self-reported sleep quality despite objectively measured sleep parameters in the post-acute rehab setting. PubMed •• Martin JL, Fiorentino L, Jouldjian S, et al. Poor self-reported sleep quality predicts mortality within one year of inpatient post-acute rehabilitation among older adults. Sleep. 2011;34(12):1715–21. This prospective cohort study found increased mortality associated with poor self-reported sleep quality despite objectively measured sleep parameters in the post-acute rehab setting. PubMed
54.
go back to reference Troxel WM, Germain A, Buysse DJ. Clinical management of insomnia with brief behavioral treatment (BBTI). Behav Sleep Med. 2012;10(4):266–79.PubMedCrossRef Troxel WM, Germain A, Buysse DJ. Clinical management of insomnia with brief behavioral treatment (BBTI). Behav Sleep Med. 2012;10(4):266–79.PubMedCrossRef
55.
go back to reference Roszkowska J, Geraci SA. Management of insomnia in the geriatric patient. Am J Med. 2010;123:1087–90.PubMedCrossRef Roszkowska J, Geraci SA. Management of insomnia in the geriatric patient. Am J Med. 2010;123:1087–90.PubMedCrossRef
56.
go back to reference Garzon C, Guerrero JM, Aramburu O, et al. Effect of melatonin administration on sleep, behavioral disorders and hypnotic drug discontinuation in the elderly: a randomized, double-blind, placebo-controlled study. Aging Clin Exp Res. 2009;21(1):38–42.PubMed Garzon C, Guerrero JM, Aramburu O, et al. Effect of melatonin administration on sleep, behavioral disorders and hypnotic drug discontinuation in the elderly: a randomized, double-blind, placebo-controlled study. Aging Clin Exp Res. 2009;21(1):38–42.PubMed
57.
go back to reference Heisel MJ, Duberstein PR, Lyness JM, et al. Screening for suicide ideation among older primary care patients. J Am Board Fam Med. 2010;23(2):260–9.PubMedCrossRef Heisel MJ, Duberstein PR, Lyness JM, et al. Screening for suicide ideation among older primary care patients. J Am Board Fam Med. 2010;23(2):260–9.PubMedCrossRef
58.
go back to reference Cohen A, Chapman BP, Gilman SE, et al. Social inequalities in the occurrence of suicidal ideation among older primary care patients. Am J Geriatr Psychiatry. 2010;18(12):1146–54.PubMedCrossRef Cohen A, Chapman BP, Gilman SE, et al. Social inequalities in the occurrence of suicidal ideation among older primary care patients. Am J Geriatr Psychiatry. 2010;18(12):1146–54.PubMedCrossRef
59.
go back to reference • Tang WK, Chen YK, Liang HJ, et al. Cerebral microbleeds and suicidality in stroke. Psychosomatics. 2012;53:439–45. This prospective cohort study found increased suicidal ideation among older stroke patients, particularly in those with lobar or thalamic hemorrhages. PubMedCrossRef • Tang WK, Chen YK, Liang HJ, et al. Cerebral microbleeds and suicidality in stroke. Psychosomatics. 2012;53:439–45. This prospective cohort study found increased suicidal ideation among older stroke patients, particularly in those with lobar or thalamic hemorrhages. PubMedCrossRef
60.
go back to reference Taylor MH, Grossbery GT. The growing problem of illicit substance abuse in the elderly: a review. Prim Care Companion CNS Disord. 2012;14(4). doi:10.4088/PCC.11r01320. Taylor MH, Grossbery GT. The growing problem of illicit substance abuse in the elderly: a review. Prim Care Companion CNS Disord. 2012;14(4). doi:10.​4088/​PCC.​11r01320.
61.
go back to reference Mottam PG, Wilson K, Strobl JJ. Antidepressants for depressed elderly. The Cochrane Library. 2009. p. 1-69. Mottam PG, Wilson K, Strobl JJ. Antidepressants for depressed elderly. The Cochrane Library. 2009. p. 1-69.
62.
go back to reference Pinquart M, Duberstein PR, Lyness JM. Treatments for later-life depressive conditions: a meta-analytic comparison of pharmacotherapy and psychotherapy. Am J Psychiatry. 2006;163:1493–501.PubMedCrossRef Pinquart M, Duberstein PR, Lyness JM. Treatments for later-life depressive conditions: a meta-analytic comparison of pharmacotherapy and psychotherapy. Am J Psychiatry. 2006;163:1493–501.PubMedCrossRef
63.
go back to reference Andreeva VA, Galan P, Torres M, et al. Supplementation with B vitamins or n-3 fatty acids and depressive symptoms in cardiovascular disease survivors: ancillary findings from the supplementation with FOLate, vitamins B-6 and B-12 and/or Omega-3 fatty acids (SU.FOL.OM3) randomized trial. Am J Clin Nutr. 2012;96(1):208–14.PubMedCrossRef Andreeva VA, Galan P, Torres M, et al. Supplementation with B vitamins or n-3 fatty acids and depressive symptoms in cardiovascular disease survivors: ancillary findings from the supplementation with FOLate, vitamins B-6 and B-12 and/or Omega-3 fatty acids (SU.FOL.OM3) randomized trial. Am J Clin Nutr. 2012;96(1):208–14.PubMedCrossRef
64.
go back to reference Dyck CH, Lyness JM, Rohrbaugh RM, et al. Cognitive and psychiatric effects of vitamin B12 replacement in dementia with low serum B12 levels: a nursing home study. Int Psychogeriatr. 2009;21(1):138–47.PubMedCrossRef Dyck CH, Lyness JM, Rohrbaugh RM, et al. Cognitive and psychiatric effects of vitamin B12 replacement in dementia with low serum B12 levels: a nursing home study. Int Psychogeriatr. 2009;21(1):138–47.PubMedCrossRef
65.
go back to reference Schellander R, Donnerer J. Antidepressants: clinically relevant drug interactions to be considered. Pharmacology. 2012;86(4):203–15.CrossRef Schellander R, Donnerer J. Antidepressants: clinically relevant drug interactions to be considered. Pharmacology. 2012;86(4):203–15.CrossRef
66.
go back to reference Lavretsky H. Complementary and alternative medicine use for treatment and prevention of late-life mood and cognitive disorders. Aging health. 2009;5(1):61–78.PubMedCrossRef Lavretsky H. Complementary and alternative medicine use for treatment and prevention of late-life mood and cognitive disorders. Aging health. 2009;5(1):61–78.PubMedCrossRef
68.
go back to reference George MS, Lisanby SH, Avery D, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry. 2010;67:507–16.PubMedCrossRef George MS, Lisanby SH, Avery D, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry. 2010;67:507–16.PubMedCrossRef
69.
go back to reference Kayser S, Bewernick BH, Grubert C, et al. Antidepressant effects, of magnetic seizure therapy and electroconvulsive therapy, in treatment-resistant depression. J Psychiatr Res. 2011;45:569–76.PubMedCrossRef Kayser S, Bewernick BH, Grubert C, et al. Antidepressant effects, of magnetic seizure therapy and electroconvulsive therapy, in treatment-resistant depression. J Psychiatr Res. 2011;45:569–76.PubMedCrossRef
70.
go back to reference Holzheimer PE, Kelley ME, Gross RE, et al. Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Arch Gen Psychiatry. 2012;69(2):150–8.CrossRef Holzheimer PE, Kelley ME, Gross RE, et al. Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Arch Gen Psychiatry. 2012;69(2):150–8.CrossRef
71.
go back to reference Hatfield JP, Hirsch JK, Lyness JM. Functional impairment, illness burden, and depressive symptoms in older adults: does type of social relationship matter? Int J Geriatr Psychiatry. 2013;28:190–8.PubMedCrossRef Hatfield JP, Hirsch JK, Lyness JM. Functional impairment, illness burden, and depressive symptoms in older adults: does type of social relationship matter? Int J Geriatr Psychiatry. 2013;28:190–8.PubMedCrossRef
72.
go back to reference Sirey J, Hannon CP, D’Angelo D, et al. A community treatment intervention AdVancing Active Treatment in the Elderly (ACTIVATE): a pilot study. J Gerent Soc Work. 2012;55:382–91.CrossRef Sirey J, Hannon CP, D’Angelo D, et al. A community treatment intervention AdVancing Active Treatment in the Elderly (ACTIVATE): a pilot study. J Gerent Soc Work. 2012;55:382–91.CrossRef
Metadata
Title
Geriatric Psychiatry Review: Differential Diagnosis and Treatment of the 3 D’s - Delirium, Dementia, and Depression
Authors
Lisa J. Downing
Thomas V. Caprio
Jeffrey M. Lyness
Publication date
01-06-2013
Publisher
Current Science Inc.
Published in
Current Psychiatry Reports / Issue 6/2013
Print ISSN: 1523-3812
Electronic ISSN: 1535-1645
DOI
https://doi.org/10.1007/s11920-013-0365-4

Other articles of this Issue 6/2013

Current Psychiatry Reports 6/2013 Go to the issue

Geriatric Disorders (H Lavretsky, Section Editor)

Recent Advances in Neuroimaging Biomarkers in Geriatric Psychiatry

Schizophrenia and Other Psychotic Disorders (SJ Siegel, Section Editor)

Clinical Application of Actigraphy in Psychotic Disorders: A Systematic Review

Sexual Disorders (JP Fedoroff, Section Editor)

Pornography, Sex Crime, and Paraphilia